Literature DB >> 9744249

Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam, 1994-95.

I Sharifi1, A R Fekri, M R Aflatonian, A Nadim, Y Nikian, A Kamesipour.   

Abstract

Between August 1994 and July 1995, 11,517 primary school children aged 6-11 years in the south-eastern Iranian city of Bam, comprising 5560 (48.3%) girls and 5957 (51.7%) boys, were examined for the presence of active lesions or scars of cutaneous leishmaniasis (CL). There was a trend towards increasing prevalence with age, the prevalence being 10.7% in 6-year-old and 20% in > or = 11-year-old children. Overall, 1.3% of the children had active lesions and 14.3% had scars. There was no significant difference between the sexes in the prevalence of active lesions and/or scars. Of the children examined, 54 (0.5%) had leishmaniasis recidivans: 19 girls (35.2%) and 35 boys (64.8%). The number of active lesions or scars per child ranged from 1 to 10. The majority (82.3%) had 1 lesion, 12.4% had 2 lesions, and 5.3% had > or = 3. The average number of lesions was 1.08 (1.03 in girls and 1.18 in boys). The face was the part of the body most commonly involved (63.6%), followed by the hands (20.9%), legs (12.8%) and other parts of the body (2.7%). Examination of isolates from 14 children revealed that in 13 (92.9%) the causal organism was Leishmania tropica and in the other (7.1%) L. major. The survey indicates that the geographical distribution of CL is far wider than previously thought. It also shows that Bam is a suitable areas for a vaccine field trial.

Entities:  

Keywords:  Age Factors; Asia; Biology; Child; Clinical Research; Demographic Factors; Dermatological Effects; Developing Countries; Diseases; Iran; Leishmaniasis; Measurement; Parasitic Diseases; Physiology; Population; Population Characteristics; Prevalence; Research Methodology; Research Report; Southern Asia; Youth

Mesh:

Year:  1998        PMID: 9744249      PMCID: PMC2305712     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  Cutaneous leishmaniasis in Kabul: observations on a 'prolonged epidemic'.

Authors:  R W Ashford; K A Kohestany; M A Karimzad
Journal:  Ann Trop Med Parasitol       Date:  1992-08

Review 2.  Cutaneous leishmaniasis: clinical aspect.

Authors:  Y Dowlati
Journal:  Clin Dermatol       Date:  1996 Sep-Oct       Impact factor: 3.541

3.  The epidemiology of cutaneous leishmaniasis in the Isfahan province of Iran. I. The reservoir. II. The human disease.

Authors:  A Nadim; M Faghih
Journal:  Trans R Soc Trop Med Hyg       Date:  1968       Impact factor: 2.184

4.  Cutaneous leishmaniasis in Saudi-Arabia: an overview.

Authors:  A Nadim; M A Seyedi-Rashti; J Ashi
Journal:  Bull Soc Pathol Exot Filiales       Date:  1979 May-Jun

5.  Chronic lupoid leishmaniasis. Evaluation by polymerase chain reaction.

Authors:  A Z Momeni; S Yotsumoto; D R Mehregan; A H Mehregan; D A Mehregan; M Aminjavaheri; H Fujiwara; J Tada
Journal:  Arch Dermatol       Date:  1996-02

6.  Epidemiology of cutaneous leishmaniasis in Afghanistan. Part I: Zoonotic cutaneous leishmaniasis.

Authors:  A Nadim; E Javadian; M K Noushin; A K Nayil
Journal:  Bull Soc Pathol Exot Filiales       Date:  1979 Jan-Feb

7.  Urban cutaneous leishmaniasis in Kerman, Southeast Iran.

Authors:  M A Seyedi-Rashti; K Keighobadi; A Nadim
Journal:  Bull Soc Pathol Exot Filiales       Date:  1984 May-Jun

8.  Cutaneous leishmaniasis in south-western Ethiopia: Ocholo revisited.

Authors:  G Mengistu; T Laskay; T Gemetchu; D Humber; M Ersamo; D Evans; H Teferedegn; M A Phelouzat; D Frommel
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Mar-Apr       Impact factor: 2.184

  8 in total
  18 in total

1.  Leishmaniasis at the End of the Millennium.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.725

2.  Evaluation of the efficacy of intralesional Glucantime plus niosomal zinc sulphate in comparison with intralesional Glucantime plus cryotherapy in the treatment of acute cutaneous leishmaniasis, a randomized clinical trial.

Authors:  Saeedeh Farajzadeh; Rahim Ahmadi; Saman Mohammadi; Abbas Pardakhty; Maryam Khalili; Mahin Aflatoonian
Journal:  J Parasit Dis       Date:  2018-10-13

3.  Comparison between intralesional injection of zinc sulfate 2 % solution and intralesional meglumine antimoniate in the treatment of acute old world dry type cutaneous leishmaniasis: a randomized double-blind clinical trial.

Authors:  Saeedeh Farajzadeh; Maryam Hakimi Parizi; Ali Akbar Haghdoost; Azadeh Mohebbi; Saman Mohammadi; Abbas Pardakhty; Sana Eybpoosh; Amireh Heshmatkhah; Behrooz Vares; Simin Saryazdi; Ali Reza Fekri; Elham Mohebbi
Journal:  J Parasit Dis       Date:  2014-11-22

4.  Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection.

Authors:  M M Gicheru; J O Olobo; C O Anjili; A S Orago; F Modabber; P Scott
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults.

Authors:  Pouran Layegh; Sara Rahsepar; Amir Ali Rahsepar
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

6.  Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.

Authors:  Ramtin Hadighi; Mehdi Mohebali; Patrick Boucher; Homa Hajjaran; Ali Khamesipour; Marc Ouellette
Journal:  PLoS Med       Date:  2006-04-18       Impact factor: 11.069

7.  Comparative Testing of Susceptibility Levels of Phlebotomus sergenti, the Main Vector of Anthroponotic Cutaneous Leishmaniasis, to Conventional Insecticides Using Two Capture Methods in Kerman City, Southeastern Iran.

Authors:  Yavar Rassi; Shahla Ebrahimi; Mohammad Reza Abai; Hassan Vatandoost; Amir Ahmad Akhavan; Abass Aghaie Afshar
Journal:  J Arthropod Borne Dis       Date:  2021-03-31       Impact factor: 1.198

8.  Cutaneous leishmaniasis in bam: a comparative evaluation of pre- and post-earthquake years (1999-2008).

Authors:  I Sharifi; N Nakhaei; Mr Aflatoonian; M Hakimi Parizi; Ar Fekri; H Safizadeh; Mr Shirzadi; Mm Gooya; A Khamesipour; A Nadim
Journal:  Iran J Public Health       Date:  2011-06-30       Impact factor: 1.429

9.  The emergence of anthroponotic cutaneous leishmaniasis following the earthquake in southern villages of bam district, southeastern iran, 2010.

Authors:  Mohammad Reza Aflatoonian; Iraj Sharifi; Somayeh Poursmaelian; Maryam Hakimi-Parizi; Nasser Ziaali
Journal:  J Arthropod Borne Dis       Date:  2013-06-10       Impact factor: 1.198

10.  WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study.

Authors:  Afif Ben Salah; Pierre A Buffet; Gloria Morizot; Nathalie Ben Massoud; Amor Zâatour; Nissaf Ben Alaya; Nabil Bel Haj Hamida; Zaher El Ahmadi; Matthew T Downs; Philip L Smith; Koussay Dellagi; Max Grögl
Journal:  PLoS Negl Trop Dis       Date:  2009-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.